| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 03/30/2004 | US6713089 Under acidic conditions; nonsteroid antiinflammatory nsaid; crushing strength |
| 03/30/2004 | US6713087 Method of producing submicron particles of a labile agent and use thereof |
| 03/30/2004 | CA2274144C Somatostatin antagonists |
| 03/30/2004 | CA2243504C New 19-nor-pregnene derivatives |
| 03/30/2004 | CA2136233C Health supplements containing phyto-oestrogens, analogues or metabolites thereof |
| 03/25/2004 | WO2004024673A1 Amino-propanol derivatives |
| 03/25/2004 | WO2004023870A1 Human slt transgenic animal |
| 03/25/2004 | WO2004011012A3 Stem cells for treating pancreatic damage |
| 03/25/2004 | WO2004004638A3 Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects |
| 03/25/2004 | WO2004000801A3 Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions |
| 03/25/2004 | WO2003104207A3 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 03/25/2004 | WO2003084941A3 Hydroxamic acid derivatives |
| 03/25/2004 | WO2003080070A3 Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer |
| 03/25/2004 | WO2003077949A3 Methods of treating diabetes using pde 11a inhibitors |
| 03/25/2004 | WO2003072195A3 Method for administering glp-1 molecules |
| 03/25/2004 | WO2003054156A3 Novel g proein-coupled receptor, gave7 |
| 03/25/2004 | WO2003040134A9 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof |
| 03/25/2004 | WO2003031472A3 Insulin mimetic amino acid sequences |
| 03/25/2004 | WO2003027081A3 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
| 03/25/2004 | WO2002072832A3 Therapeutic binding molecules |
| 03/25/2004 | WO2002063006A3 Receptors and membrane-associated proteins |
| 03/25/2004 | US20040060077 Using dietary restriction to lower serum insulin levels and function as tool in treatment and prevention of alzheimer's diseases |
| 03/25/2004 | US20040059140 14(15)-unsaturated 15- and/or 16-substituted androgens with mixed androgen-progrestational profile |
| 03/25/2004 | US20040059132 Reacting an indolin-2-one derivative with substituted benzyl halide to form substituted N-benzyl indolin-2-one derivatives have an affinity for oxytocin receptors |
| 03/25/2004 | US20040059130 Benz(f)indole compounds useful for Inflammatory Diseases |
| 03/25/2004 | US20040059089 Comprises receptor protein for controlling gene expression in transgenic cells; for diagnosis, prevention and treatment of heart, tumor and urogenital disorders |
| 03/25/2004 | US20040059004 10-aryl-11h-benzo[b]fluorene derivatives and analogs for medicinal use |
| 03/25/2004 | US20040058980 Useful aroyl pyrrole heteroaryl methanones and methanols |
| 03/25/2004 | US20040058922 Tyrosine inhibitor; immunosuppressants; antiarthritic agents; autoimmune diseases; antiproliferative agent |
| 03/25/2004 | US20040058892 Antidiabetic agents |
| 03/25/2004 | US20040058868 Using insulin receptor substrate and histone deacetylase inhibitor; regenerating insulin sensitivity |
| 03/25/2004 | US20040058867 Management of the consequences of fetal programming |
| 03/25/2004 | US20040058854 Synergistc therapy; bioavailability |
| 03/25/2004 | US20040058850 Using caspase inhibitor; antiinflammatory agents |
| 03/25/2004 | US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
| 03/25/2004 | US20040058358 Lipid metabolism transcription factor |
| 03/25/2004 | US20040057979 Methods for treating inflammation-mediated conditions of the eye |
| 03/25/2004 | CA2497067A1 Amino-propanol derivatives |
| 03/24/2004 | EP1399554A2 Immunoglobulin superfamily proteins |
| 03/24/2004 | EP1399441A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 03/24/2004 | EP1399436A2 Oxytocin agonists |
| 03/24/2004 | EP1399430A1 Oxazol/ thiazol-derivatives activators of the hppar-alpha receptor |
| 03/24/2004 | EP1399406A2 Novel estrogen receptor ligands and methods i |
| 03/24/2004 | EP1399206A2 Hydrophobic dopamine agonists administered to the dermis |
| 03/24/2004 | EP1399205A2 Enhanced systemic absorption of intradermally delivered substances |
| 03/24/2004 | EP1399175A2 Therapeutic use of rank antagonists |
| 03/24/2004 | EP1399166A1 A PHARMACEUTICAL COMBINATION COMPRISING EITHER (S)-2-ETHOXY-3- 4-(2- 4-METHANE SULFONYL OXYPHENYL ETHOXY) PHENYL] PROPANOIC ACID OR 3- 4- 2-(4-TERT- BUTOXY CARBONYL AMINOPHENYL) ETHOXY] PHENYL -(s)-2-ETHOXY PROPANOIC ACID AND A SULONYLUREA |
| 03/24/2004 | EP1399155A2 Small molecules useful in the treatment of inflammatory disease |
| 03/24/2004 | EP1399154A1 3-fluoro-pyrrolidines as antidiabetic agents |
| 03/24/2004 | EP1399142A1 Use of acetyl l-carnitine in association with the biotin for the treatment of patients with type 2 insulin-resistant diabetes mellitus |
| 03/24/2004 | EP1399133A2 Sustained-release composition comprising lactic acid-glycolic acid copolymer and process for producing the same |
| 03/24/2004 | EP1200399B1 Vitamin d3 analogs |
| 03/24/2004 | EP1196416B1 Substituted purine derivatives as inhibitors of cell adhesion |
| 03/24/2004 | EP0998930B1 Azasteroid compound for treating alopecia, hirsutism and seborrhea |
| 03/24/2004 | CN1484650A Urocortin proteins and uses thereof |
| 03/24/2004 | CN1484644A Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/24/2004 | CN1484537A Pharmacentical preparation for douches and/or irrigations of natural or puthological cavities in human body |
| 03/24/2004 | CN1484526A Perturbed membrane-binding compounds |
| 03/24/2004 | CN1483831A Process for obtaining insulin and insulin derivatives having correctly bonded crystine bridges |
| 03/24/2004 | CN1142911C Compounds with growth hormone releasing properties |
| 03/24/2004 | CN1142772C Lipophilic microparticles containing protein drug or antigen and formulation comprising same |
| 03/24/2004 | CN1142753C Skin patches for providing testosterone |
| 03/23/2004 | US6710088 Inorganic ion receptor-active compounds |
| 03/23/2004 | US6710063 Activators of PPAR delta |
| 03/23/2004 | US6710054 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/23/2004 | US6710050 Pharmaceutical composition and the process for its preparation |
| 03/23/2004 | US6710039 Unsaturated 14,15-cyclopropane-androstanes, a method for their production and pharamceutical compositions containing these compounds |
| 03/23/2004 | US6709849 Yeast cells cultured in presence of alternating electric field having specific frequency and specific field strength |
| 03/23/2004 | US6709831 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 03/18/2004 | WO2004022716A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 03/18/2004 | WO2004022630A2 Water-soluble polymer alkanals |
| 03/18/2004 | WO2004022582A1 Peptidomimetic drugs |
| 03/18/2004 | WO2004022551A1 Furan or thiophene derivative and medicinal use thereof |
| 03/18/2004 | WO2004022128A2 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 03/18/2004 | WO2004022086A1 Adrenocortical hormone secretion controller |
| 03/18/2004 | WO2004022032A2 Pharmaceutical dosage form comprising a sulfite compound |
| 03/18/2004 | WO2004009596A3 Pyrazolopyrimidines as kinase inhibitors |
| 03/18/2004 | WO2004000204A8 Labelled somatostatin analogs backbone cyclized through metal complexation |
| 03/18/2004 | WO2003102012A9 New etonogestrel esters |
| 03/18/2004 | WO2003100434A3 Diagnostic and therapeutic use of the arginine vasopressin receptor 2 (avpr2) |
| 03/18/2004 | WO2003099192A3 Bis-aromatic alkanols |
| 03/18/2004 | WO2003094830A3 Novel azacyclic ethynyl derivatives |
| 03/18/2004 | WO2003043652A3 The use of leptin in fertility |
| 03/18/2004 | WO2002076435A3 Lipid profile modulation with steroids |
| 03/18/2004 | US20040054145 Truncated cd200 |
| 03/18/2004 | US20040054133 Multiple sclerosis-related superantigen |
| 03/18/2004 | US20040054130 Insulin potentiating peptides |
| 03/18/2004 | US20040053993 Compositions of tocol-soluble therapeutics |
| 03/18/2004 | US20040053955 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives |
| 03/18/2004 | US20040053951 Non-peptide GnRH agents, pharmaceutical compositions, and methods for their use |
| 03/18/2004 | US20040053941 Substituted pyrazine derivatives |
| 03/18/2004 | US20040053925 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
| 03/18/2004 | US20040053924 Reacting pyrrolo(2,3-d)pyrimidin-4-one derivative containing a leaving group with a aromatic or heteroaromatic amine, hydroxy, marcaptan etc. in presence of a polar solvent and a catalyst |
| 03/18/2004 | US20040053898 For organ specific therapy; for treatment of menopausal symptoms, hormone-deficiency diseases and neurodegenerative diseases |
| 03/18/2004 | US20040053838 Measuring serum IGF-I and/or IGF-I binding protein levels after birth of patient to obtain IGF-I or IGF-I binding protein level and correlating said level with in utero baseline level based on gestational age matched mean levels |
| 03/18/2004 | US20040053833 Relates to regulation of activity of NET (ERP/SAP-2) protein and to compounds which modify or regulate NET protein activity; methods of screening for agonists or antagonists of NET in order to identify new pro- or anti-angiogenic compounds |
| 03/18/2004 | US20040053281 Comprises enzymatic polypeptide associated with fatty acid metabolism for diagnosing, treating and preventing cancer, neurodegenerative, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders |
| 03/18/2004 | US20040052855 Pouring a dissolved biodegradable polymer and a drug in a low water soluble solvents, a surfactant and homogenizing, filtering, washing and freeze drying |
| 03/18/2004 | CA2498297A1 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 03/18/2004 | CA2497901A1 Furan or thiophene derivative and medicinal use thereof |